The Research and Development Team at Synnovation Therapeutics is responsible for discovering and developing innovative small molecule therapies targeting key driver mechanisms in cancers. Leveraging their expertise in medicinal chemistry and cancer biology, the team focuses on building a diverse pipeline of novel targeted therapies and advancing these agents into clinical trials to improve patient outcomes in oncology.
View all